New inhibitors of dopamine β-hydroxylase

No abstract is available for this paper.

• Publication year

  1977

• Venue

  Advances in Enzyme Regulation

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/0065-2571(77)90020-6
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Role of brain monoamines in release of gonadotropin before proestrus in the cyclic rat.

  1975cited by this paper
• Antihypertensive effect of a dopamine beta hydroxylase inhibitor, bupicomide: A comparison with hydralazine

  1975cited by this paper
• Phenopicolinic acid, a new microbial product inhibiting dopamine beta-hydroxylase.

  1975cited by this paper
• Biochemical and Biological Studies on Dopastin, an Inhibitor of Dopamine β-Hydroxylase

  1974cited by this paper
• Inhibition of dopamine-b-hydroxylase in manic patients. A clinical trial and fusaric acid.

  1974cited by this paper
• Effects of 5-(n-butyl)-picolinamide (SCH 10595), a dopamine-beta-hydroxylase inhibitor, on serotonin and catecholamine metabolites in brain.

  1974cited by this paper
• Structure and Synthesis of Dopastin, an Inhibitor of Dopamine β-Hydroxylase

  1974cited by this paper
• BEHAVIORAL EFFECTS OF A NEW DOPAMINE-β-HYDROXYLASE INHIBITOR (FUSARIC ACID) IN MAN

  1974cited by this paper
• Evidence for a peripheral effect of fusaric acid, a dopamine beta-hydroxylase inhibitor, on serotonin metabolism.

  1974cited by this paper
• Inhibition of brain dopamine- -hydroxylase activity by methimazole.

  1973cited by this paper
• Pharmacology of fusaric acid in man

  1973cited by this paper
• 5-hydroxyindole levels in rat brain after inhibition of dopamine -hydroxylase.

  1972cited by this paper
• The clinical trial of a new hypotensive agent, "fusaric acid (5-butylpicolinic acid)": the preliminary report.

  1971cited by this paper
• In vivo inhibition of dopamine beta-hydroxylase by 1-phenyl-3-(2-thiazolyl)-2-thiourea (U-14,624).

  1970cited by this paper
• Inhibition of dopamine β-hydroxylase by fusaric acid (5-butylpicolinic acid) in vitro and in vivo

  1970cited by this paper
• 2‐Mercaptobenzothiazole, an inhibitor of dopamine β‐hydroxylase

  1970cited by this paper
• Comparative effects of p-chlorophenylalanine, p-chloroamphetamine and p-chloro-N-methylamphetamine on rat brain norepinephrine, serotonin and 5-hydroxyindole-3-acetic acid☆

  1970cited by this paper
• INHIBITION OF DOPAMINE β-HYDROXYLASE BY AROMATIC AND ALKYL THIOUREAS

  1969cited by this paper
• Inhibition by disulfiram of the accelerated turnover of catecholamines in the adrenal glands of exercised rats

  1968cited by this paper
• Radioimmunoassay for Rat Luteinizing Hormone with Antiovine LH Serum and Ovine LH-131I∗

  1968cited by this paper
• The determination of tryptophan in plasma, liver, and urine.

  1967cited by this paper
• Increased synthesis of norepinephrine and epinephrine in the intact rat during exercise and exposure to cold.

  1966cited by this paper
• Inhibition of dopamine‐β‐oxidase by dietbyldithiocarbamate

  1965cited by this paper
• STUDIES ON THE PURIFICATION AND CHARACTERIZATION OF 3,4-DIHYDROXYPHENYLETHYLAMINE BETA-HYDROXYLASE.

  1965cited by this paper
• The inhibition of dopamine-β-oxidase by chelating agents

  1964cited by this paper
• A SENSITIVE METHOD FOR SPECTROPHOTOFLUOROMETRIC ASSAY OF CATECHOLAMINES.

  1964cited by this paper
• The enzymatic conversion of 3,4-dihydroxyphenylethylamine to norepinephrine.

  1960cited by this paper
• Identification and chemical assay of norepinephrine in brain and other tissues.

  1958cited by this paper

• The scalar exotic resonances $$X(3915), X(3960), X_0(4140)$$ X ( 3915 )

  2023cites this paper
• Theoretical perspective on mononuclear copper-oxygen mediated C–H and O–H activations: A comparison between biological and synthetic systems

  2022cites this paper
• Medicinal Chemistry of Isocyanides.

  2021cites this paper
• Theory Demonstrated a "Coupled" Mechanism for O2 Activation and Substrate Hydroxylation by Binuclear Copper Monooxygenases.

  2019cites this paper
• Copper active sites in biology.

  2014cites this paper
• Decreased norepinephrine release in anterior hypothalamus of NaCl-sensitive spontaneously hypertensive rats during high NaCl intake.

  1991cites this paper
• The Neuronal Basis of Salt Sensitivity

  1989cites this paper
• High NaCl diet reduces hypothalamic norepinephrine turnover in hypertensive rats.

  1988cites this paper
• The neural basis of salt sensitivity in the rat: altered hypothalamic function.

  1988cites this paper
• Drug Discovery at the Enzyme Level

  1987cites this paper
• Design and kinetic characterization of multisubstrate inhibitors of dopamine beta-hydroxylase.

  1986cites this paper
• Inhibition of dopamine β-hydroxylase by 2-mercapto-1-methylimidazole

  1983cites this paper
• Dopamine accumulation after dopamine beta-hydroxylase inhibition in rat heart as an index of norepinephrine turnover.

  1982cites this paper
• PHARMACOLOGIC MODIFICATION OF ADRENALINE NEURONS IN RAT BRAIN

  1980cites this paper
• A32390A, a new biologically active metabolite. II. Isolation and structure.

  1978cites this paper
• A32390A, a new biologically active metabolite. I. Discovery and fermentation studies.

  1978cites this paper